Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III - Report - MDSpire

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III

  • By

  • Xu-jie Zhou

  • Le-ting Zhou

  • Celine C. Berthier

  • Swapan K. Nath

  • June 2, 2026

  • 0 min

Share

Clinical Report: Progress in Precision Medicine for Immune-Mediated Disorders

Overview

This editorial summarizes advancements in precision medicine for immune-mediated disorders, focusing on the integration of big data and artificial intelligence.

Background

Understanding the heterogeneity in inflammatory responses among patients with immune-mediated disorders is crucial. Traditional classifications often fail to capture the complexity of these diseases.

Data Highlights

No specific numerical data or trial data is provided in the editorial.

Key Findings

The editorial series emphasizes a shift from single-disease silos to a genetic perspective on immune-mediated disorders, supported by various studies.

Clinical Implications

The findings highlight the potential for integrating genetic and molecular data in disease classification.

Conclusion

The editorial emphasizes the importance of precision medicine in understanding immune-mediated disorders.

Related Resources & Content

  1. Frontiers in Medicine, Editorial: Molecular informatics in personalized medicine, volume II
  2. Frontiers in Oncology, Editorial: Evaluating differentiation therapy and biomarkers in myeloid malignancies
  3. Frontiers in Immunology, Editorial: Exploring immunological tolerance in allergy treatment through AIT
  4. GINA 2025 report
  5. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease
  6. EULAR recommendations for the management of rheumatoid arthritis, 2025 update
  7. asco ai in oncology — Transcriptomic Classifier for Predicting Neoadjuvant Immunotherapy Response in Triple-Negative Breast Cancer
  8. Microsoft Word - GINA 2025_with figures_tracked for archive_deidentified.docx
  9. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1 - PubMed
  10. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - PubMed
  11. The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis
  12. Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease - PMC
  13. Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus - University of Miami

Original Source(s)

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III

  • by Xu-jie Zhou, Le-ting Zhou, Celine C. Berthier, Swapan K. Nath

  • June 2, 2026

Related Content

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

Efficacy of Splenectomy in Treating Refractory Autoimmune Hemolytic Anemia Linked to Systemic Lupus Erythematosus: A Case Study with Mechanistic Analysis

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.